Why AI Voice Agents Fail More Than You Think—And How To Get It Right

The future of customer engagement will not be fully human or fully automated. It will be collaborative.

Zwischenzug: Why Prompting Is Losing Its Opening Advantage

The prompt is the opening. It only gets you to a position. The game is won in the middle, in the moves you insert between the model’s output and your acceptance of it.

A Biologist Explains Why Some Humans Get Freckles And Others Never Do

Why do some people get freckles and others don’t? A biologist breaks down the genetics, sun exposure and evolutionary trade-offs behind them.

Where AI Agents Fit Inside Venture Capital Workflows

From my perspective, AI agents work best in the parts of venture capital that are repetitive, document-heavy and easy to audit.

Robotaxi Companies Need To Stop It With The Right Seat Safety Drivers

Several companies have tried to declare they met a major milestone by having “nobody behind the wheel” and moving supervision to the passenger seat. It’s a bad idea

Marshall Reveals Next-Generation Acton And Stanmore Wireless Speakers

Marshall has updated its Acton and Stanmore wireless Bluetooth speakers by adding Auracast technology and an improved sound that delivers a wider stereo soundstage.

The Founder Paradox: Why Your Biggest Brand Asset Is Also Your Biggest AI Liability

A company whose AI identity depends entirely on its founder hasn’t built a company in AI systems. It has built an extension of a person.

Moving With Confidence In The AI Era: Why Native Architecture For Documentation Is Key

AI will absolutely change how documents are created, reviewed and delivered. But the winners won’t be the organizations that automate the fastest—they’ll be the ones that automate with control.

Your Company’s Biggest Legal Risk Is Outside Its Walls—AI Can Help You Find It

The signs of legal risk are everywhere and appear early, from regulatory filings and incident data to market shifts and litigation patterns.

Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy

Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital’s purchase of Asembia may spur even more specialty pharmacy deals.